SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING AFTER A PRIOR AUTOTRANSPLANT – REDUCED INTENSITY ALLOGENEIC VERSUS AUTOLOGOUS TRANSPLANTATION

There is no standard therapy for multiple myeloma (MM) relapsing after an autotransplant. We compared the outcomes of a 2(nd) autotransplant (N=137) with those of an allotransplant (N=152) after non-myeloablative or reduced-intensity conditioning (NST/RIC) in 289 subjects reported to the CIBMTR from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Freytes, Cesar O., Vesole, David H., LeRademacher, Jennifer, Zhong, Xiaobo, Gale, Robert Peter, Kyle, Robert A., Reece, Donna E., Gibson, John, Schouten, Harry C., McCarthy, Philip L., Lonial, Sagar, Krishnan, Amrita Y., Dispenzieri, Angela, Hari, Parameswaran N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947725/
https://ncbi.nlm.nih.gov/pubmed/24270389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2013.187
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados